Adam Woodrow - 08 Aug 2023 Form 4 Insider Report for Paratek Pharmaceuticals, Inc.

Role
President & Chief Commercial
Signature
/s/ William M. Haskel, Attorney-in-Fact for Adam Woodrow
Issuer symbol
N/A
Transactions as of
08 Aug 2023
Net transactions value
$0
Form type
4
Filing time
10 Aug 2023, 20:41:06 UTC
Previous filing
22 Dec 2022
Next filing
21 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTK Common Stock Award $0 +98,750 +15% $0.000000 750,034 08 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on March 30, 2021 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan that vested on August 8, 2023.